Ionis Pharmaceuticals (IONS) Short-term Investments (2009 - 2026)

Ionis Pharmaceuticals' Short-term Investments history runs 18 years deep, the most recent figure standing at $1.7 billion for Q2 2026.

• In Q2 2026, Short-term Investments fell 14.46% year-over-year to $1.7 billion; the TTM figure through Jun 2026 stood at $1.7 billion (down 14.46% YoY), while the FY2025 annual figure was $2.3 billion, up 12.14% from the prior year.
• Short-term Investments for Q2 2026 stood at $1.7 billion, down from $1.7 billion in the prior quarter.
• The five-year high for Short-term Investments was $2.3 billion in Q4 2025, with the low at $1.5 billion in Q2 2022.
• The 5-year median for Short-term Investments is $1.9 billion (2023), against an average of $1.9 billion.
• The sharpest annual moves came in 2022 and 2026: Short-term Investments surged 37.3% in 2022, then declined 14.46% in 2026.
• Ionis Pharmaceuticals' Short-term Investments stood at $1.7 billion in 2022, then advanced by 12.95% to $1.9 billion in 2023, then rose by 6.4% to $2.1 billion in 2024, then rose by 12.14% to $2.3 billion in 2025, then decreased by 26.06% to $1.7 billion in 2026.
• Business Quant data shows IONS's Short-term Investments at $1.7 billion in Q2 2026, $1.7 billion in Q1 2026, and $2.3 billion in Q4 2025.